Zegalogue (dasiglucagon) is a medication used in emergencies for when you have dangerously low blood sugar. It's chemically different from glucagon, but works in similar ways to raise your blood sugar levels. Zegalogue (dasiglucagon) comes as a prefilled autoinjector and a prefilled syringe that you inject under your skin. It's administered either in your lower stomach, buttocks, thigh, or outer upper arm. Zegalogue (dasiglucagon) commonly causes stomach-related side effects, like nausea and vomiting. This medication is brand name only.
Emergency treatment of very low blood sugar in people age 6 years and older
Zegalogue (dasiglucagon) is a glucagon receptor agonist that works to raise blood sugar (glucose) levels. It does this by triggering your liver to make more glucose and by breaking down glycogen (a stored form of glucose) in your body.
Source: DailyMed
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report to your care team if they continue or are bothersome):
Comes prefilled, so no need to mix or prepare the dose
Can get your blood sugar levels back to a safe level in as quickly as 10 minutes
Available as an autoinjector, which might be easier to use for some people
Only available as a brand medication
Caps on both autoinjector and prefilled syringe contain latex, so might not be safe for people with latex allergy
Not recommended for children younger than 6 years old
Zegalogue (dasiglucagon) is a subcutaneous injection. This means you should inject it under the skin. You can do so in your lower belly or thigh, buttocks, or the outer part of your upper arm.
Don't inject Zegalogue (dasiglucagon) through your clothes because the medication might not work.
Be sure that you and your caregivers read the Instructions For Use that come with Zegalogue (dasiglucagon) autoinjector or Zegalogue (dasiglucagon) prefilled syringe so you know how to use the medication before an emergency situation happens.
Store Zegalogue (dasiglucagon) in your refrigerator and keep it in its red protective case, but don't freeze it. Zegalogue (dasiglucagon) can also be kept at room temperature, but it will only be good for up to a year or until the expiration date, whichever comes first. Don't put Zegalogue (dasiglucagon) back into the refrigerator after it's been stored at room temperature.
Teach yourself and your family members how to recognize and treat the symptoms of low blood sugar. The following are some common symptoms of low blood sugar: feeling shaky or hungry, being nervous or anxious, fast heartbeat, sweating or body chills, confusion, feeling sleepy, weakness, or low energy.
Call for emergency medical help or contact a healthcare provider right away after you use Zegalogue (dasiglucagon), even if the medication helps you feel better.
After you use a dose of Zegalogue (dasiglucagon), throw away the syringe, autoinjector, and needles in an FDA-approved sharps disposal container to prevent needle-stick injuries. If you don't have a sharps container, you can use a container that's made of heavy-duty plastic, can be closed with a tight lid, and leak-resistant, like a laundry detergent bottle. Be sure to label the container so people know there's sharp objects inside.
Zegalogue (dasiglucagon) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
People with pheochromocytoma (a type of hormone-releasing tumor) shouldn't use Zegalogue (dasiglucagon). Doing so can trigger the release of catecholamines (stress hormones) which can raise your blood pressure.
Risk factors: Insulinoma
Zegalogue (dasiglucagon) can be dangerous for those with insulinoma (tumors in the pancreas that release extra insulin). While Zegalogue (dasiglucagon) will raise blood sugar in people with insulinoma at first, this rise in blood sugar can trigger the body to release insulin, which can further lower your blood sugar. For this reason, people with insulinoma shouldn't use this medication. If you develop low blood sugars after using Zegalogue (dasiglucagon), take some fast-acting sugar right away to raise your blood sugar back to normal levels.
Zegalogue (dasiglucagon) can cause an allergic reaction in some people. If you develop a rash, trouble breathing, or low blood pressure after using Zegalogue (dasiglucagon), get medical help right away.
Risk factors: Starvation | Adrenal insufficiency | Chronic hypoglycemia
Zegalogue (dasiglucagon) raises blood sugar by breaking down the glucose stores (glycogen) in your body. Zegalogue (dasiglucagon) doesn't work well for people who don't have enough glucose stored up. This includes people who haven't eaten enough for long periods of time, people with adrenal insufficiency, and people with chronic hypoglycemia. If you have one of these conditions, it's best to treat low blood sugars with fast-acting glucose instead of Zegalogue (dasiglucagon).
The typical dose of Zegalogue (dasiglucagon) is 0.6 mg injected under the skin as needed for very low blood sugar. If your blood sugar doesn't rise after 15 minutes, you can repeat the dose once.
Emergency treatment of very low blood sugar in people age 6 years and older
Severely low blood sugar (hypoglycemia) in adults and children age 2 years and older
Severely low blood sugar (hypoglycemia) in adults and children
Before certain diagnostic imaging procedures (e.g., MRI, CT scan) in adults
By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.
Hövelmann, U. (2018). Pharmacokinetic and pharmacodynamic characteristics of dasiglucagon, a novel soluble and stable glucagon analog. Diabetes Care.
Johns Hopkins Medicine. (n.d.). Insulinoma.
National Cancer Institute. (2020). Pheochromocytoma.
National Institute of Diabetes and Digestive and Kidney Diseases. (2018). Definition & Facts of Adrenal Insufficiency & Addison's Disease.
Novo Nordisk A/S. (n.d.). Find confidence in being prepared. Get to know ZEGALOGUE® (dasiglucagon) injection.
Novo Nordisk Inc. (2021). GlucaGen® (glucagon) for injection, for subcutaneous, intramuscular or intravenous use [package insert].
Okabayashi, T., et al. (2013). Diagnosis and management of insulinoma. World Journal of Gastroenterology.
U.S. Food and Drug Administration. (2021). Sharps disposal containers.
Zealand Pharma A/S. (2021). Instructions for use: Zegalogue® (ze’ gah log) (dasiglucagon) injection - 0.6 mg/0.6 mL emergency use for very low blood sugar single-dose autoinjector injection, for subcutaneous use.
Zealand Pharma A/S. (2021). Instructions for use: Zegalogue® (ze’ gah log) (dasiglucagon) injection - 0.6 mg/0.6 mL emergency use for very low blood sugar single-dose prefilled syringe injection, for subcutaneous use.
Zealand Pharma US. (2023). Zegalogue- dasiglucagon injection, solution [package insert]. DailyMed.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.